Search

everythinglearnresearchcommunity

for

Search:↓

Differences in growth factors in platelet-rich plasma therapy for hair loss can vary between patients and can be influenced by the devices used, possibly leading to inconsistent results.

An 87-year-old woman was diagnosed with type 3 autoimmune polyendocrine syndrome and had multiple autoimmune issues.

Increased HIF-1α is linked to the inflammation and severity of hidradenitis suppurativa, suggesting treatments that lower HIF-1α could help.

PRP injections significantly improve hair regrowth in alopecia areata.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Timely treatment of eosinophilic asthma in rheumatic disease patients can prevent organ damage.

Hair color is not a risk factor for developing alopecia areata.

Chicken feather gene mutation helps understand human hair disorders.

A man with hypoparathyroidism had other health issues that led to a diagnosis of a rare autoimmune disorder, APS-1.

Mothers with alopecia areata have a higher risk of adverse birth outcomes.

Stress-related substance P may lead to hair loss and negatively affect hair growth.

Blocking certain fat production can reverse skin inflammation and hair loss.

Consider benefits and risks of new alopecia treatments for safety.

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

Sun-exposed skin shows different cell activity and gene expression, suggesting targets to prevent skin aging and cancer.

A 6-year-old girl with Turner syndrome also had psoriasis, alopecia areata, and trachyonychia.

Exosomes could revolutionize skin disease treatment and healing.

COVID-19 may trigger alopecia areata, but more research is needed.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Leontopodium alpinum extract may help reduce hair shedding by keeping hair in the growth phase longer.

Early skin biopsy helps diagnose and manage severe skin conditions in babies.

Epimedium extract helps increase skin pigmentation and could be a new treatment for conditions with reduced pigmentation.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

Alopecia treatment should use a modern, combined approach to effectively address hair loss.

The document concludes that hair is complex, with a detailed growth cycle, structure, and clinical importance, affecting various scientific and medical fields.